Dyslipidemia in Infants: Challenges in Diagnosis and Management

Authors

  • Asma Marzouk Pediatrics and Neonatology departement, Yasminette hospital, Faculty of Medecine of Tunis. University El Manar, Ben Arous, Tunisie
  • Nour Jelalia Pediatrics and Neonatology departement, Yasminette hospital, Faculty of Medecine of Tunis. University El Manar, Ben Arous, Tunisie
  • Oumayma Mzoughi Pediatrics and Neonatology departement, Yasminette hospital, Faculty of Medecine of Tunis. University El Manar, Ben Arous, Tunisie
  • Saad Ayeb Pediatrics and Neonatology departement, Yasminette hospital, Faculty of Medecine of Tunis. University El Manar, Ben Arous, Tunisie
  • Rahma Thebti Pediatrics and Neonatology departement, Yasminette hospital, Faculty of Medecine of Tunis. University El Manar, Ben Arous, Tunisie
  • Asma Bouaziz Pediatrics and Neonatology departement, Yasminette hospital, Faculty of Medecine of Tunis. University El Manar, Ben Arous, Tunisie

DOI:

https://doi.org/10.62438/tunismed.v102i12.4494

Keywords:

infant, Familial Hyperlipidemia, Therapeutic management, Multidisciplinary , Complications

Abstract

Dyslipidemia in infants is a rare condition characterized by abnormal levels of lipids in the blood, such as cholesterol and triglycerides. Early diagnosis poses a challenge due to nonspecific symptoms and lipid criteria differing from adults. Through two clinical cases of familial dyslipidemia (Type 1 Familial Hypercholesterolemia and Type 2b Combined Familial Hyperlipidemia), we highlight the diagnostic and therapeutic challenges encountered in infants, emphasizing the importance of a multidisciplinary approach in care and early screening. In the first case, a 3-month-old boy with a family history of dyslipidemia was diagnosed during bronchiolitis, revealing milky serum, pseudohyponatremia, and abnormal lipid profile. His Type 1 familial hyperlipidemia was confirmed by lipid electrophoresis. Despite dietary management and breastfeeding, he developed severe pancreatitis, successfully treated with intensive care. The second case involved a girl who presented at 3 months with vomiting and irritability. Laboratory tests indicated pseudohyponatremia, hematologic abnormalities, and lipid disturbances. Her Type 2b familial hyperlipidemia was confirmed by lipid electrophoresis. She responded well to a specialized diet, experiencing few pancreatitis episodes without meeting clinical or radiological severity criteria.

Downloads

Download data is not yet available.

References

Jayaram S, Meera S, Kadi S, Sreenivasa N. An Interesting Case of Familial Homozygous Hypercholesterolemia—A Brief Review. Indian J Clin Biochem. juill 2012;27(3):309‑13.

Management of Dyslipidemias in Children - DynaMed [Internet]. [cité 29 mai 2024]. Disponible sur: https://www.dynamed.com/management/management-of-dyslipidemias-in-children#GUID-78466972-8724-470E-B126-3E38E7547B95

Filippo MD. Aspects génotypiques et phénotypiques des dyslipidémies primitives rares affectant le métabolisme des lipoprotéines riches en triglycérides.

Singh S, Bittner V. Familial hypercholesterolemia--epidemiology, diagnosis, and screening. Curr Atheroscler Rep. 2015;17(2):482.

Brun N, Rodondi N. [How to deal with familial dyslipidemia in clinical practice?]. Rev Med Suisse. 7 mars 2012;8(331):494‑6, 498‑500.

US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, et al. Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA. 9 août 2016;316(6):625‑33.

Defesche JC, Gidding SS, Harada-Shiba M, Hegele RA, Santos RD, Wierzbicki AS. Familial hypercholesterolaemia. Nat Rev Dis Primer. 7 déc 2017;3:17093.

Chora JR, Iacocca MA, Tichý L, Wand H, Kurtz CL, Zimmermann H, et al. The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification. Genet Med Off J Am Coll Med Genet. févr 2022;24(2):293‑306.

Capra ME, Biasucci G, Crivellaro E, Banderali G, Pederiva C. Dietary intervention for children and adolescents with familial hypercholesterolaemia. Ital J Pediatr. 22 juin 2023;49(1):77.

Cohen RZ, Freeman AJ. Pancreatitis in Children. Pediatr Clin North Am. déc 2021;68(6):1273‑91.

Patni N, Ahmad Z, Wilson DP. Genetics and Dyslipidemia. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al., éditeurs. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000 [cité 29 mai 2024]. Disponible sur: http://www.ncbi.nlm.nih.gov/books/NBK395584/

Hyperlipidemies_-_Dr_Peretti.pdf [Internet]. [cité 25 juill 2023]. Disponible sur: https://www.gfhgnp.org/wordpress/wp-content/themes/kTheme-v2-gfhgnp/pdf/publications/lyon-2015/Hyperlipidemies_-_Dr_Peretti.pdf

Padda IS, Fabian D, Johal GS. Familial Combined Hyperlipidemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cité 29 mai 2024]. Disponible sur: http://www.ncbi.nlm.nih.gov/books/NBK592399/

Additional Files

Published

2024-12-01

Issue

Section

Case report

Categories